Implementation of the NICE guidelines for the primary prevention of mortality from ventricular tachyarrhythmias: implications for UK electrophysiology centres; activity modelling from the UK-HEART study
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

  • Published on:
    Re: Implementation of NICE guidance on the use of implantable cardioverter defibrillators
    Dear Editor,

    We thank Drs Plummer and McComb for their interest in our estimate of the implications of the recently published NICE guidelines for United Kingdom electrophysiology centres [1]. We agree that an assessment of the workload implications of these guidelines is important for resource planning.

    Using data gathered in clinical trials designed for different ends will always require assumptions and can therefor...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Implementation of NICE guidance on the use of implantable cardioverter defibrillators
    • C J Plummer, SpR in Cardiology, Consultant Cardiologist
    • Other Contributors:
      • J M McComb

    Dear Editor,

    The activity monitoring analysis of the UK-HEART study published by Gall et al. [1] is very welcome. They calculate that screening of 551 ambulant patients with stable heart failure according to NICE guidance [2] would result in 142 electrophysiology studies (EPS) and the implantation of 50 implantable cardioverter defibrillators (ICDs). Thus 9% of their population were found to have a primary preve...

    Show More
    Conflict of Interest:
    None declared.